Ironwood abandons deal with AstraZeneca for lesinurad, once hoped to be a gout blockbuster Ironwood Pharmaceuticals has decided to walk away from its 2016 deal to license AstraZeneca’s billion-dollar gout […]
Ironwood dumps AstraZeneca gout drug Zurampic—and lays off 125 in the process Zurampic, a drug AstraZeneca once laid out more than $1 billion to get its hands on, has wound […]
Acorda inks Ampyra generic settlements as it waits for patent appeal news Late last month, a court refused to block copies of Acorda’s Ampyra leading up to a patent appeal […]
Mayo Clinic pinpoints genes that raise the risk of triple-negative breast cancer The ability to identify women who face the highest risk of triple-negative breast cancer could save lives, but […]
Janssen, Bayer to close South Korean plants due to limited demand Janssen and Bayer are joining a long list of pharma companies closing their manufacturing facilities in South Korea. And […]